Press release
Thiamine Market Demonstrates Long-Term Growth Potential At 8.8% CAGR
Thiamine Market
Projected Expansion and Market Value of the Thiamine Market by 2030
The thiamine market is poised to expand significantly, reaching a valuation of $2.3 billion by 2030. This growth corresponds to a compound annual growth rate (CAGR) of 8.8%. Several factors are contributing to this upward trajectory, including increased attention to preventive healthcare nutrition, heightened demand for clean-label vitamin ingredients, and the broadening development of nutraceutical products. Additionally, thiamine's growing incorporation in functional foods, along with rising investments toward manufacturing capacity enhancement, supports this positive outlook. Key trends anticipated for the forecast period include wider vitamin fortification in food products, the expanding use of thiamine in dietary supplements, growing applications in animal nutrition, the development of pharmaceutical-grade vitamins, and advancements focused on improving bioavailability and stability.
The thiamine market size has grown strongly in recent years. It will grow from $1.5 billion in 2025 to $1.64 billion in 2026 at a compound annual growth rate (CAGR) of 9.7%. The growth in the historic period can be attributed to increasing awareness of micronutrient deficiencies, expansion of fortified food programs, rising consumption of dietary supplements, growth of pharmaceutical vitamin formulations, increased use in animal feed nutrition.
Download a free sample of the thiamine market report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=16552&type=smp&utm_source=OpenPR&utm_medium=Paid&utm_campaign=Aug_PR
Important Contributors Leading the Thiamine Market
A number of prominent players are driving the thiamine market forward. These include BASF SE, Koninklijke DSM N.V., The Nature's Bounty Co. Ltd., Zhejiang Medicine Co. Ltd., Swanson Health Products Inc., NOW Health Group Inc., Nutricost LLC, Solgar Inc., Tokyo Chemical Industry Co. Ltd., Puritan's Pride Inc., Aland Nutraceuticals Group, Anhui Tiger Biotech Co. Ltd., Caisson Laboratories Inc., General Nutrition Centers Inc., Huazhong Pharmaceutical Co. Ltd., Xinfa Pharmaceutical Co. Ltd., Jiangxi Tianxin Pharmaceutical Co. Ltd., Acebright Pharmaceuticals Group Co. Ltd., Anhui BBCA Biochemical Co. Ltd., Jiangsu Yibang Pharmaceutical, and Nippon Chemical.
In a notable development from April 2023, Netherlands-based Koninklijke DSM NV, specializing in nutrition, health, and sustainable living, completed its acquisition of Switzerland's Firmenich International SA for around $18.08 billion. This strategic move aims to form a leading global entity under the name DSM-Firmenich, combining expertise in nutrition, health, and beauty. Firmenich SA is an established provider of thiamine (Vitamin B1) across various applications supporting health and nutrition.
View the full thiamine market report:
https://www.thebusinessresearchcompany.com/report/thiamine-global-market-report?utm_source=OpenPR&utm_medium=Paid&utm_campaign=Aug_PR
Emerging Innovations Shaping the Thiamine Market
Leading companies in the thiamine sector are actively developing cutting-edge products to maintain their competitive edge. One significant area of innovation is vitamin B1 deficiency infusions, which administer thiamine directly into the bloodstream via intravenous (IV) methods.
For example, in June 2023, Indian pharmaceutical firm Lupin Limited introduced a thiamine hydrochloride injection (USP) available in multi-dose vials containing 200 mg/2 mL (100 mg/mL). This injectable form offers a rapid and effective treatment option for patients facing issues with oral absorption - such as those with gastrointestinal disorders or severe deficiencies requiring immediate intervention. Such advancements provide healthcare professionals with dependable tools to restore vitamin B1 levels promptly, reducing the risks associated with prolonged deficiency.
Detailed Segmentation of the Global Thiamine Market
This report categorizes the thiamine market into distinct segments for a clearer understanding:
1) By Product Type:
- Thiamine Mononitrate
- Thiamine Hydrochloride
- Thiamine Pyrophosphate
2) By Form:
- Tablets and Capsules
- Liquid
- Powder
3) By Application:
- Food and Beverages
- Pharmaceuticals
- Animal Feed
- Dietary Supplements
- Other Applications
Further subsegments provide more granularity, such as:
- Thiamine Mononitrate being available as powder, granules, and tablets
- Thiamine Hydrochloride offered in powder, injectable form, and tablets
- Thiamine Pyrophosphate available as powder and injectable form
This detailed classification helps stakeholders identify specific market opportunities and track developments in each category.
The 2026 edition of our market reports now delivers enhanced analytical coverage through market attractiveness scoring and analysis, total addressable market (TAM) analysis, company scoring matrix graphics and tables, Excel-based forecasting dashboards, market hotspots infographics, key technologies and future trend analysis, plus updated graphics and tables.
Reach out to us:
The Business Research Company: https://www.thebusinessresearchcompany.com/,
Americas +1 310-496-7795,
Europe +44 7882 955267,
Asia & Others +44 7882 955267 & +91 8897263534,
Email us at info@tbrc.info.
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Learn More About The Business Research Company
With over 17500+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.Our flagship product, the Global Market Model (GMM), is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Thiamine Market Demonstrates Long-Term Growth Potential At 8.8% CAGR here
News-ID: 4615121 • Views: …
More Releases from The Business Research Company
Triple Negative Breast Cancer Market Demonstrates Long-Term Growth Potential At …
An in-depth look into the triple negative breast cancer market reveals promising growth and significant advancements in treatment options. As research intensifies and new therapies emerge, this sector is poised for notable expansion and increased innovation in the coming years.
Projected Market Growth of the Triple Negative Breast Cancer Market by 2030
The market for triple negative breast cancer is anticipated to experience substantial growth, reaching a valuation of $1.48…
Treatment-Resistant Depression Market Outlook Signals Expansion To $2.59 Billion …
The treatment-resistant depression market is on track for significant expansion as new therapies and technologies emerge to address persistent challenges in managing this complex condition. With ongoing advancements in personalized medicine and digital health, this sector is expected to evolve rapidly in the coming years. Here's an in-depth look at the market size, key players, influential trends, and detailed segmentation shaping the industry's outlook.
Forecast of the Treatment-Resistant Depression Market Size…
Traumatic Brain Injuries Assessment Market Report 2026 Market Outlook Supported …
The assessment of traumatic brain injuries (TBI) is a rapidly evolving field, driven by technological advancements and a growing need for precise and timely diagnosis. As healthcare providers seek more effective tools to evaluate brain trauma, the market for TBI assessment is poised for notable expansion. Below is an in-depth look at how this market is expected to develop, the leading players involved, and the trends shaping its future.
Traumatic Brain…
Transthyretin Amyloid Cardiomyopathy (ATTR-CM) Treatment Market Insights Highlig …
The treatment landscape for transthyretin amyloid cardiomyopathy (ATTR-CM) is on the brink of remarkable growth, driven by innovative medical approaches and increased focus on rare diseases. As advancements continue to emerge, this market is set to transform significantly by 2030, offering new hope for patients affected by this challenging cardiac condition.
Projected Market Growth of the ATTR-CM Treatment Market
The transthyretin amyloid cardiomyopathy treatment market is anticipated to expand dramatically,…
More Releases for Thiamine
Impact Of Increasing Demand For Dietary Supplements On The Thiamine Market: Stra …
Use code ONLINE20 to get 20% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
How Large Will the Thiamine Market Size By 2025?
The thiamine market has experienced robust expansion recently, projected to escalate from its 2024 valuation of $1.37 billion to $1.5 billion in 2025, reflecting a compound annual growth rate of 9.4%. This upward trajectory during the past period is attributable…
Thiamine: A Leading Driver Behind Impact Of Increasing Demand For Dietary Supple …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts._x000D_
_x000D_
What Will the Thiamine Industry Market Size Be by 2025?_x000D_
In the past few years, the size of the thiamine market has been expanding rapidly. The market, which is projected to increase from $1.37 billion in 2024 to $1.51 billion in 2025, is expected to experience a compound annual…
Top Factor Driving Thiamine Market Growth in 2025: Impact Of Increasing Demand F …
What industry-specific factors are fueling the growth of the thiamine market?
The growing demand for dietary supplemen*ts is expected to boost the thiamine market. dietary supplemen*ts, which help people meet their nutritional needs, are in greater demand due to increasing health consciousness, preventive healthcare trends, and a focus on immune system support. Thiamine is a key nutrient in these supplements, supporting vital functions such as energy production, heart health, and metabolism.…
Key Thiamine Market Trend for 2025-2034: Innovative Thiamine Infusion Products F …
What Is the Future Outlook for the Thiamine Market's Size and Growth Rate?
In recent times, the thiamine market has witnessed a rapid escalation in its size. The projection for its growth is from $1.37 billion in 2024 to $1.51 billion in 2025, showcasing a compound annual growth rate (CAGR) of 10.4%. The significant growth observed in the past is credited to the upsurge in fortification initiatives, extended range of…
Vitamin B1 (Thiamine Hydrochloride) Market
The "Vitamin B1 (Thiamine Hydrochloride) Market" is expected to reach USD xx.x billion by 2031, indicating a compound annual growth rate (CAGR) of xx.x percent from 2024 to 2031. The market was valued at USD xx.x billion In 2023.
Growing Demand and Growth Potential in the Global Vitamin B1 (Thiamine Hydrochloride) Market, 2024-2031
Verified Market Research's most recent report, "Vitamin B1 (Thiamine Hydrochloride) Market: Global Industry Trends, Share, Size, Growth, Opportunity and…
Global Thiamine Market Research Report
Thiamine, also well-known as thiamin or vitamin B1, is found in several foods involving yeast, cereal grains, beans, nuts, and meat. It benefits to turn food into energy to keep the nervous system healthy. Thiamine is extensively used in foods, animal feed, and pharmaceutical preparations.
According to the report analysis, 'Global Thiamine Market, 2021-2027' states that Brother Enterprises Holding Co., Ltd., DSM Nutritional Products AG, Huazhong Pharmaceutical Co., Ltd., Jiangsu…
